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ABSTRACT
p53 tumor suppressor is a transcription factor that
controls cell cycle and genetic integrity. In response
to genotoxic stress p53 activates DNA repair, cell cy-
cle arrest, apoptosis or senescence, which are ini-
tiated via p53 binding to its specific DNA response
elements (RE). The consensus p53 DNA RE consists
of two decameric palindromic half-site sequences.
Crystallographic studies have demonstrated that two
isolated p53 DNA-binding core domains interact with
one half-site of the p53 DNA REs suggesting that one
p53 tetramer is bound to one RE. However, our recent
3D cryo-EM studies showed that the full-length p53
tetramer is bound to only one half-site of RE.
Here, we have used biochemical and electron mi-
croscopy (EM) methods to analyze DNA-binding of
human and murine p53 tetramers to various p53
DNA REs. Our new results demonstrate that two p53
tetramers can interact sequence-specifically with
one DNA RE at the same time. In particular, the EM
structural analysis revealed that two p53 tetramers
bind one DNA RE simultaneously with DNA posi-
tioned between them. These results demonstrate a
mode different from that assumed previously for the
p53-DNA interaction and suggest important biologi-
cal implications on p53 activity as a transcriptional
regulator of cellular response to stress.
INTRODUCTION
The p53 transcription factor, encoded by theTP53 gene, is a
major tumor suppressor that controls genetic integrity and
cell proliferation (1). In response to various forms of stress,
p53 is activated and accumulates in the nucleus, where it reg-
ulates the transcription of numerous target genes via inter-
action with its specific DNA response elements (RE), com-
ponents of transcription machinery and chromatin remod-
eling factors (2–4). Depending on the type and amount of
stress, and the type of tissue, the p53-dependent response
leads to DNA repair, cell cycle arrest, metabolic reprogram-
ming, apoptosis or senescence, thus preventing the develop-
ment of cancer (5). Mutations in the TP53 gene are associ-
ated with more than a half of all forms of human malignan-
cies (6–8).
Human p53 protein is a polypeptide of 393 amino acid
residues in length that forms tetramers in solution, in a
dimer-of-dimers manner (9–15). p53 consists of five do-
mains: transcription activation domain (residues 1–67), a
proline-rich region (residues 67–98), a central core domain
(residues 98–303), a nuclear localization signal-containing
region (303–323), the oligomerization domain (residues
323–363) and the C-terminal basic domain (residues 363–
393) (16,17). Unlike other transcription factors, p53 has
two DNA-binding domains. One is the core domain re-
sponsible for binding to sequence-specific DNA REs lo-
cated near promoters of the p53 target genes (18–21). Most
of the cancer-associated missense mutations occur in the
sequence-specific DNA-binding core domain, where muta-
tions either disrupt protein–DNA interactions directly or
alter its overall conformation (22). The second is the C-
terminal domain of p53 that forms stable complexes with
non-specific DNA, including mismatched DNA, double-
strand breaks and single-strandedDNA (23,24). It has been
proposed that the C-terminus of p53 also provides addi-
tional anchorage to specific DNA sites via non-specific
flanking interactions, thus stabilizing the whole complex
(25–30). The latter was supported by electron microscopy
(EM) structures of the full length p53 and p53-DNA com-
plex where the C-terminal domains were localized in the
close proximity to DNA (31,32).
A p53 consensus DNA RE is composed of a tandem
of two decameric palindromic sequences (half-sites) 5′-
RRRCWWGYYY-3′, where R = purine, Y = pyrimidine
and W is either A or T. There is a variability in compo-
sition of p53 REs, thus two half-sites can be separated by
a spacer DNA, typically 0–13 bp in length and many p53
DNAREs have varying numbers of half-sites (19,20,22,33–
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37). Early biochemical studies in conjunction with electron
microscopy showed that p53 binds DNAREs as a tetramer,
with both dimers of each tetramer thought to be engaged
in the binding (9–14,38). High molecular order complexes
were also reported where multiples of p53 tetramers were
bound to DNA REs presumably, as explained at that time,
via tetramer to tetramer interactions (12).
The mechanism of DNA recognition by p53 was pro-
posed on the basis of the crystallographic structure of the
isolated p53 core domain bound to a specific DNA target
(22). This finding was corroborated by more recent struc-
tures of the p53 isolated core domains in complex with the
half-site and full-size RE DNAs (39–42). Based on these
data a model of p53-DNA complex has been suggested
where all four core domains of the p53 tetramer bind the
full RE sequence in a fashion where the DNA is ‘wrapped’
up by p53 protein (22,39–44). However, it is hard to recon-
cile this model with DNA-binding in a chromatin context,
where DNA is packed in nucleosomes. This model has been
challenged by cryo-EM studies of the full length p53. A re-
cent structure of the full-length murine p53 tetramer indi-
cated that the p53 active complex is formed by a dimer of
dimers where the monomers interact via their juxtaposed
amino-terminal (N) and carboxy-terminal (C) domains to
form N/C nodes (31).
The structure of the full-length p53-DNA complex
showed that each of the p53 dimers contribute one core
domain to form a complex with only one half-site of p53
DNA RE. This type of interaction suggests that a pair of
core domains is located on one side of the tetrameric com-
plex, while the other pair is on the opposite side, thus mak-
ing the binding of the four core domains from the same p53
tetramer to the one 20 bp-long response element unlikely.
This configuration of a p53 tetramer is further supported
by the subsequent EM analysis of the murine full-length
p53 tetramer in complex with specific DNA RE (32). The
arrangement of core domains engaged in DNA-binding
was identical to that described by crystallographic studies
(32,40,41). The EM structures suggest that while one p53
tetramer is bound to one half-site of p53 RE, the other half-
site remains unoccupied. This model of interactions raises
questions about a role of the second half-site in DNA RE
and whether it will be possible for the second p53 tetramer
to bind the same DNA RE. Such a possibility would only
be viable when two p53 tetramers bind p53 RE from the op-
posite sides of DNA, one tetramer per half-site using DNA
RE sequence.
To test this possibility we used biochemical and EM
approaches. Modified gel-shift experiments of p53-DNA
complexes cross-linked with glutaraldehyde were used to
demonstrate that two p53 tetramers can bind one consensus
DNA RE leading to a p53 double tetramer-DNA complex.
Our experiments revealed the same results for both murine
and human p53 proteins, suggesting a conserved mecha-
nism. Furthermore, the p53 double tetramer-DNA com-
plexes were extracted from native protein gels by a modified
gel-to-grid technique and visualized using negative stain
electronmicroscopy. Image analysis confirmed that two p53
tetramers are bound to one DNA RE simultaneously with
DNA located in between two tetramers. Our results indicate
a mechanism of joint p53 tetramer interaction with DNA
RE that can facilitate looping of distal p53 DNA binding
sites and provide a dose-dependent response to stress, thus
having important biological implications on p53 transcrip-
tional activity in regulating cellular fate.
MATERIALS AND METHODS
Recombinant p53 and p53-DNA complex preparation
Recombinant murine and human p53 proteins were ex-
pressed in the baculoviral system using Sf9 cells, purified
and tested for homogeneity as described previously (31).
Freshly purified proteins were used for DNA-binding as-
says using various double-stranded DNA (dsDNA) targets,
which were prepared by annealing their complementary
DNA strands (Table 1).
p53-DNA complexes were formed by mixing p53 with
a DNA target of choice and the final volume of DNA-
binding mixtures was 50 l, of which the DNA template
was typically 5 l (maximum of 250 ng per reaction) and
the remaining volume was made of the p53 protein with
maximum of 2.5 g of p53 per reaction, and the reaction
buffer based on Tris (25 mMTris-HCl, pH 7.5, 2 mMDTT,
100 mM NaCl, 1 mM ADP, 5 mM of MgCl2) or HEPES
(20 mM HEPES, pH 7.5, 2 mM DTT, 100 mM NaCl, 10
mMADP, 5 mM ofMgCl2) where indicated. When HEPEs
was used as a buffer for crosslinking and DNA-binding re-
actions the recombinant p53 proteins were also eluted in
HEPES-based buffer. Different ratios of DNA and protein
were used at the initial stages of this work to determine the
best DNA-binding conditions as described in the results.
p53-DNA reaction mixtures were prepared in 1.5 ml Ep-
pendorf tubes, incubated on ice for 5 min, then for 15 min
in a thermostated mixer at 25◦C with 450 rpm shaking af-
ter every 20 s. This was followed by the addition of 0.025%
glutaraldehyde (GA), which was freshly prepared from 25%
glutaraldehyde (Sigma) using ultra-pure water. Typically a
volume of 5 l 0.25% GA was added to 50 l reaction mix-
tures to make final concentration of GA 0.025% and incu-
bated at 25◦C for another 20 min. Reaction samples were
then loaded onto either denaturing or native protein gels us-
ing the appropriate sample-loading buffer. For initial time-
course experiments, cross-linking was initiated by the addi-
tion of various amounts of GA as described in the results.
Electro-mobility shift assays (EMSA)
Twenty bp long DNA specific and non-specific targets
were prepared by annealing their corresponding oligonu-
cleotides. Both strands of each target were 5′-labeled by
an IR-dye, IR800 for specific (gadd45) DNA and IR700
for non-specific DNA, resulting in green and red signals
when detected by the LI-COR Odyssey CLx system. p53
protein–DNA complexes were prepared and cross-linked
with 0.025% GA as described above and loaded onto ei-
ther 4–12% MOPS SDS gel (Invitrogen) or Native PAGE
Novex 4–16% Bis-Tris gel (Invitrogen). The loading buffers
were DTT-containing 3x loading buffer (BioRad) for dena-
turing PAGE and 5% glycerol and 0.01% Ponceau S load-
ing buffer for the native gels (Invitrogen). Typically a 20
l sample of each reaction was loaded in each well. 1x
 at Birkbeck College, U
niversity of London on A
pril 12, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2016 3
Table 1. Oligonucleotide DNA targets used in p53 DNA-binding experiments. Arrows (→ or ←) represent p53 RE quarter sites. (→← represent p53 RE
half-sites). Corresponding forward (fwd) and the complementary reverse (rev) oligonucleotides were annealed to each other produce the double-stranded
DNA targets. DNA targets #1-9 were as reported in (13). DNA sequences from natural promoters were adapted from p21 (19), gadd45 (50), MCK (51),
RGC (18),Mdm2 (52) and bax (54)
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MOPS SDS buffer (Invitrogen) was used for the denatur-
ing PAGE. Anode (25 mM imidazole. pH 7) and cathode
(50 mM tricine, 7.5mM imidazole, 0.002% Coomassie blue-
G250. pH 7) buffers were used for the Native PAGE.
Denaturing electrophoresis was carried out at 4◦C, or on
ice for approximately 3.5 h at 150 V, resulting in 50 kDa
Mwproteinmarkermigrating approximately three-quarters
of the gel length. Native electrophoresis was also carried
at 4◦C, for ∼3.5 h at 150 V, 8–10 mA. The cathode buffer
for the latter was replaced when the current dropped to 2
mA, approximately every hour and a half. Gels were an-
alyzed by either coomassie or silver staining for protein
content and by scanning with LI-COR Odyssey system to
detect IR-dye labelled DNA. Gels containing IR-labelled
DNA were analyzed and quantified using ImageStudioLite
software (LI-COR). For immunoanalysis (Western blot-
ting) gels were transferred onto nitrocellulose C (Amer-
sham) using semidry BioRad apparatus at 15 V for 1 h and
CAPS transfer buffer (10mMCAPS, 20%Methanol, 0.02%
SDS), blocked with 5% fat-free milk, probed with PAb
240 as primary antibody (in 5% fat-free milk) overnight at
4◦C and rabbit anti-mouse horseradish peroxidase (HRP) -
conjugated secondary antibody (Dako) for 1 h at room tem-
perature, washed and developed using PierceTM enhanced
chemiluminescence (ECL) Western blotting substrate.
Gel-to-grid transfer
p53-DNA complexes were prepared and separated as de-
scribed above and resolved on Native (Blue) PAGE Novex
4–16% Bis-Tris gels (Invitrogen). The position of the p53-
DNA complexes in the gel were determined by detecting
the IR-dye labelledDNA targets used in the p53-DNAcom-
plexes by the Odyssey Imaging System (LI-COR). Only one
side of the plastic gel cast was removed before the scanning
procedure, so that the positions of the complexes could be
marked on the remaining side of the cast using a permanent
marker, which was visible under IR light and thus could be
re-verified by a quick scan. Zones of the gel containing p53-
DNA complexes of interest were excised by using a scalpel.
The glow-discharged carbon-coated copper grid was placed
carbon side facing up onto a 2 mm thick glass plate (Bio-
Rad Mini-Protean II system), an excised piece of gel was
positioned onto the grid and a 5 l droplet of electrophore-
sis buffer was placed on top of the gel slab to prevent ex-
tra drying. The blotting assembly sandwich was finalized by
placing another identical glass plate on top. A 300 g weight
(a conical glass flask filled to the weight with water) was po-
sitioned on top of the glass plate sandwich and left for 2 min
to accelerate the protein–DNA particles diffusing from gel
onto the grid (Supplementary Figure S8A). After 2 min the
grid was taken out of the glass plate sandwich and stained
with uranyl acetate as described below. Typically 3 grids and
3 gel slabs were blotted simultaneously in one assembly al-
lowing to process about 12–16 slabs cut from one 15-well
gel in about 20 min.
Electron microscopy
Rotary shadowing. The 0.025% GA cross-linked p53-
DNA complexes were allowed to adsorb to freshly cleaved
mica for 2 min. They were stained with 2% uranyl acetate
for 2 min followed by three washes in water. Air-dried mica
was rotary-shadowed with Pt-Ir alloy at an angle of 4–7◦
followed by carbon evaporation in anEdwards Coating Sys-
tem (E306A) (45). Grids were examined in a FEI CM 100
EM; images were taken with 1k x 1k TVIPS F114 slow-scan
CCD camera at x11 500 nominal EM magnification.
Negative staining. Samples were applied to carbon-coated
copper grids (square 400mesh copper grids, 3mmdiameter,
Agar Scientific) using the gel-to-grid transfer method. The
grids were then washed with 3 l buffer (100 mMNaCl, 25
mM Tris-HCl pH 7.5), blotted and stained with 3 l uranyl
acetate (2%, pH 4.5) for 2 min. The grids were blotted once
more, dried and analyzed under the microscope. A prelim-
inarily examination was carried out on a Tecnai T12 elec-
tron microscope at 120 kV to assess grid quality and sam-
ple and stain distribution followed by the data collection us-
ing Tecnai F20 FEG electron microscope. The images were
recorded under low electron-dose conditions using a Gatan
Ultrascan 4000, 4k × 4k CCD camera at a nominal mag-
nification of x50 000 (pixel size of 3.6 A˚/pixel). A range of
defocus values varying from 1.5 to 2.5mwas used for data
collection.
Image processing
Particles from the gel-to-grid transfer images were manu-
ally picked using the EMAN Boxer software package (46).
The contrast transfer function of the microscope was deter-
mined using the CTFFIND3 program and then corrected
by phase flipping (47). The images were then normalized to
the same mean grey values and standard deviation followed
by band-pass filtering to remove uneven background and
high frequency noise (with low- and high-resolution cut-offs
of 90 A˚ and 12 A˚, respectively). Alignment and classifica-
tion were performed using the IMAGIC-5 software pack-
age (48).
Surface rendering was performed using a threshold level
of ∼2 standard deviations (2) in the maps corresponding
to ∼100% of the expected mass of the complex. Figures
were generated using Chimera (49).
RESULTS
p53 forms high molecular order complexes on its specific
DNA RE
To confirm that the recombinant p53 used in our experi-
ments was a tetramer we used chemical cross-linking with
glutaraldehyde (final concentration from 0.01% to 0.5%)
followed by denaturing protein SDS-PAGE (Figure 1A).
These experiments confirmed that even at low amount of
glutaraldehyde recombinant human p53 was a tetramer in
solution, migrating as a complex of about 260 KDa molec-
ular mass range which was in agreement with all published
reports that p53 is tetrameric even at low nM concentra-
tions (10–13,15). Increasing amounts of glutaraldehyde (up
to 0.5%) caused visible change in migration due to excessive
crosslinking Figure 1A. A final concentration of 0.025% of
glutaraldehyde was chosen as optimal for all the following
experiments.
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Figure 1. p53 tetramers form high molecular order complexes on DNA RE. (A) Equal amounts of the recombinant human p53 (2.5 g) were cross-linked
with increasing concentrations of glutaraldehyde (GA). Lane 1 – 0.01%; Lane 2 – 0.025%; Lane 3 – 0.05%; Lane 4 – 0.1% and Lane 5 – 0.5%) and products
of reactions were separated using 4–12% MOPS SDS PAGE. Lane 6 – control, no GA was used. (B and C) Complexes of the recombinant human p53
with dsDNA (DNA#1, 20 bp) were cross-linked with GA (0.025%) and analyzed by 4–12%MOPS SDS PAGE stained with coomassie G-250. Increasing
amounts of p53 (0.25, 0.5, 1.25, 2.5 and 5 g) were used in (B) and increasing amounts of DNA targets with 2 g of p53 were used in (C). Products of
crosslinking resolved in a ladder-like pattern of high molecular order complexes, molecular masses of which corresponded to one, two, three, four and
higher amount of p53 tetramer per complex. Increase of DNA or protein amounts did not change the stoichiometry of complexes. Lane 6 (B) and Lane 7
(C) – controls with no GA added to p53.
To test a hypothesis that p53 forms double tetramers on
a consensus sequence-specific 20 bp DNA target, (DNA1,
Table 1) recombinant human p53 was incubated with DNA
RE, cross-linked with glutaraldehyde and analyzed on pro-
tein SDS-PAGE. The cross-linked p53-DNA complexes
were resolved in a ladder-like pattern which represented a
range of high molecular order complexes of p53 with DNA,
molecular masses of which corresponded to one, two, three,
four and higher numbers of the p53 tetramers per com-
plex with increments of ∼200–250 kDa. This result indi-
cated that in solution p53 and its specific DNA target form
complexes that comprise multiple copies of p53 tetramers
(Figure 1B and C). This type of DNA-binding by multiple
p53 tetramers was evident in all cases with different ratios of
p53 tetramers per DNA (from 1:1 to 4:1). The ratio between
single, double and triple p53 tetramers bound to DNA re-
mained proportional when different amount of p53 were
used in reactions (Figure 1B). Analogous results were ob-
tained for murine p53, indicating that protein sequence dif-
ferences between these two homologues do not affect their
DNA-binding behavior (Supplementary Figure S1).
DNA-binding of multiple p53 tetramers to DNA RE is se-
quence specific
We next examined whether this multiple DNA-binding by
p53 tetramers takes places on DNA targets that have less
and/or degenerated half-sites sequences than the consen-
sus p53 DNARE.We used DNA targets of the same length
(20 bp) with the internal sequences of the decameric half-
sites being reorganized to disrupt internal palindromic re-
peats (Figure 2A,DNA targets 1–5). The formation of com-
plexes with different dsDNA targets has been analyzed at
different concentrations of p53. The p53-DNA complexes
were formed as described above and fixed with glutaralde-
hyde (0.025%). SDS-PAGE analysis showed that the DNA-
binding by multiple p53 tetramers depends on the num-
ber of half-sites in the DNA RE. p53 could only efficiently
form high order molecular complexes with DNA targets
that have two half-sites (DNA1) (Figure 2B). The DNA tar-
gets of types 2–5 did not stimulate DNA-binding of multi-
ple p53 tetramers when compared to those in the absence
of DNA (Figure 2B, control (−) − no DNA). The com-
plexes have been clearly identified by both coomassie and
silver staining and the p53 nature of these complexes was
confirmed by immunoblotting (Figure 2).
To see whether the length of DNA targets and/or con-
ditions of cross-linking reactions could have an effect on
the observed p53-DNA complex formation we also tested
longer DNA targets which had extra 23 bp-long flanks on
both sides of the target sequences (Supplementary Table
S1) and reactions were repeated using HEPES buffer in-
stead of Tris (Supplementary Figure S2).When testedmp53
showed results similar to those observed in Figure 1 and
Supplementary Figure S1 indicating that neither change of
the length of DNA nor buffer conditions were affecting the
multiple p53 tetramers binding to DNA. Furthermore the
truncated version of mp53 lacking the last 30 amino acid
residues (mp5330) showed behavior similar to that of the
full-length mp53 protein (Supplementary Figure S2B).
Whilst it became clear that the DNA-binding by multiple
p53 tetramers was stimulated by the sequence-specific inter-
action with the DNA RE half-sites it was also essential to
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Figure 2. Multiple binding of p53 tetramers to DNA RE is sequence specific. p53 forms high molecular order complexes with DNA and this process
depends on the amount of half-sites in DNA RE. (A) DNA targets composed of different amount half-sites and quarter sites. Quarter site sequence
RRRCW depicted as → and quarter site sequence WGYYY depicted as ←, where R = purine, Y = pyrimidine and W is either A or T. The complete
half-site is→←. Different colors are used to show two adjacent half-sites.∼ – non-specific DNA sequence. (B) Recombinant p53 (murine, 1.25 and 2.5 g)
can only efficiently form high order molecular complexes with DNA targets that have both half-sites (DNA #1). p53 forms double tetramers in solution
but it is not stimulated any further by DNA targets #2–5, control – last two lanes, no DNA. Immunoblotting was done with Pab240.
examine the role of the spacer length between RE half-sites.
We tested theDNA-binding of both human andmurine p53
to DNA targets with the spacer length varying from 0 to 15
bp between theREhalf-sites (Figure 3A). Themost efficient
DNA-binding targets to form complexes larger than eight
p53 tetramers bound toDNAwere those with two half-sites
adjacent to each other (Figure 3B). Thus, DNA targets 1
and 6, both of which had no spacer between the half-sites
of RE, gave identical results for both human and murine
p53 proteins and efficiently promoted formation of com-
plexes as large as two, three and four p53 tetramers bound to
DNA.DNA targets having a spacer length of 5 bp (DNA7),
10 bp (DNA8) and 15 bp (DNA9) were less efficient in pro-
moting p53-DNAhighmolecular order complexes, with the
DNA9 target with the 15 bp linker being most efficient of
them (Figure 3B).
Another factor that may affect the DNA-binding for hu-
man and murine p53 protein tetramers was the origin of
DNA RE sequences. We analyzed six DNA targets derived
from the natural promoters where RE sequences had dif-
ferent numbers of half-site decamers: RE sequences from
gadd45 and p21 genes have two, REs from RGC, MCK
and bax have three, and RE from mdm2 have four half-
sites (Table 1, Figure 3C). All these targets promotedDNA-
binding of multiple p53 tetramers (Figure 3D). Themost ef-
ficient DNA targets for murine p53 were derived from bax
and mdm2 (Table 1, Figure 3C and D). At the same time
DNA targets derived from RGC and MCK RE sequences
were less efficient in promoting p53-DNA complexes larger
than 8 and 12 p53 tetramers. Interestingly, the human p53
showed more of the multiple tetramers DNA-binding than
its murine homologue on all natural sequences used, that is
forming more complexes with three and four p53 tetramers
bound to DNA. The observed difference could potentially
be explained by the source of the DNA sequences used, all
but one (mdm2) were from human genome.
To further test whether the spacer length shorter than 5
bp may have an effect on DNA-binding by multiple p53
tetramers we used DNA targets 21 and 31–37 (Supplemen-
tary Table S1) with spacer length varying from 0 to 7 bp be-
tween the RE half-sites (Supplementary Figure S3A). Both
human and murine p53 showed similar results in that the
DNA-binding by multiple p53 tetramers was only at its
most efficient when spacer lengthwas 0 or 1 bp (Supplemen-
tary Figure S3). This was also consistent with the data ob-
tained when DNA targets derived from TIGAR promoter
p53 RE were used. TIGAR p53 RE has almost perfect con-
sensus sequence but 2 bp spacer in between of its two half-
sites (54). When the spacer was removed the binding of
multiple p53 tetramers was increased for both human and
murine p53 (Supplementary Figure S3).
The amounts of p53 and DNA are proportional in all com-
plexes
To understand whether all p53 tetramers in the high order
complexes are bound to the DNA targets we used DNA
targets labeled with infrared (IR) dyes: IR700 dye-labeled
nonspecific dsDNA (in red) and IR800 dye-labeled specific
dsDNA (gadd45, in green) (Table 1; Figure 4A).
A combination of IR dye-labeled DNA targets in p53-
DNA binding experiments and glutaraldehyde-fixed p53-
DNA complex resolving on protein SDS-PAGE proved
to be more efficient and convenient than the traditional
DNA gel EMSA in determination of the molecular mass of
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Figure 3. DNA-binding of multiple p53 tetramers to the natural RE sequences. (A) DNA targets with different spacer length between the RE half-sites
were used to test their ability to promote high molecular order p53-DNA complexes. The half-sites depicted as →←. ∼ - non-specific DNA sequence. (B)
Both human and murine p53 form multiple complexes on DNA targets with different spacer length between the half-sites (DNA targets # 6–9). DNA
targets without any spacer (DNA targets #1 & 6) appear to be more efficient in stimulating high order complexes. (C) RE DNA targets derived from
natural promoter sequences were used to test their ability to promote high molecular order p53-DNA complexes. Gadd45 and p21 sequences have two,
RGC, MCK and bax with 3 and mdm2 have four half-sites respectively. The half-sites are depicted as →←. (D) Human p53 appears to be more efficient
in multiple binding of DNA RE targets than its murine homologue.
the p53-DNA complexes. The p53-DNA complexes cross-
linked with 0.025% glutaraldehyde were well resolved on
the SDS PAGE and even a slight change in molecular mass
due to addition of an extra dsDNA target (∼12 kDA)
was clearly seen (Figure 4A). Furthermore, p53 appears
to slightly change its conformation when bound to specific
DNA, which was indicated by the difference in migration
for p53 complexed with gadd45 and control non-specific
DNA targets (Figure 4A, p53 tetramer-DNA complexes
in green and red, respectively). The intensity of the IR800
dye in different p53-DNA complexes compared to data ob-
tained by scanning coomassie and silver-staining of these
gels showed that the amounts of p53 and DNA are propor-
tional in all complexes (Figure 4B and C).
Using IR dye-labeled DNA allowed us to measure the
difference in p53 tetramer binding on targets with different
length of spacer between RE half-sites derived from gadd45
promoter (Supplementary Table S2). We used DNA target
without spacer (gadd45 0) and fourDNA targets with spac-
ers of 1, 2, 3 and 5 bp. As a negative control we used non-
specific DNA target similar to DNA20. Consistent with
previous results (Figure 3 and Supplementary Figure S3)
the best DNA targets to stimulate multiple p53 tetrameric
complexes were those with two half-sites adjacent to each
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Figure 4. p53-DNA binding experiments with the IR dye-labeled DNA targets. (A) p53-DNA complexes were formed with two competing DNA targets –
non-specific (control DNA) and specific, gadd45 RE DNA. Each strand of the non-specific DNA was labelled with IR700 dye (red) and similarly gadd45
DNA was labelled with IR800 dye (green). An increasing amount of specific DNA target was added to p53-DNA mixtures. Increasing amounts of p53
were used for each pair of lanes. All complexes were cross-linked with 0.025%GA and separated on 4–12%MOPS SDS PAGE. 100% of non-specific target
(lanes 1 and 2) promoted only a small amount of double p53 tetramer binding to DNA, whereas the presence of specific DNA, even in small amounts,
promoted efficient DNA-binding of multiple p53 tetramers (lanes 3–6), which was highest when only the specific DNA target was used (lanes 9 and 10). (B)
Relative distribution of p53/DNA tetramers, double tetramers and triple tetramers. Density signals for different p53-DNA complexes were calculated by
density scanning of IR-signal for IR-dye-labeled DNA and image density analysis for coomassie- or silver-stained p53 gels using the same set of p53-DNA
binding reaction samples. Results are presented as ratios of normalized signal intensity. The typical distribution observed for p53 tetramers in complex
with DNA was such that compared to the single p53 tetramer-DNA complexes there was ∼2/3 of that of the double p53 tetramer-DNA complexes and
∼1/3 of that of the triple p53 tetramer-DNA complexes. (C) A schematic model of p53-DNA complexes formed by p53 tetramers binding to the DNARE
targets. Two half-sites of p53 DNA RE are required to form high molecular order complexes between p53 and DNA. Multiples of p53 tetramer form an
array interlaid with DNA.
other (Figure 5A). Thus total lack of spacer (gadd45 0) or
spacer of 1 bp length were themost efficient for bothmurine
and human p53 multiple tetramer DNA binding.
Typically the amount of double p53 tetramers complexed
with DNA was about 55–60% of the amount of single
p53 tetramers when DNA target had no spacer between
RE half-sites (gadd45 0). This proportion was decreased to
∼40% when spacer was 1 bp, followed by a sharp drop to
∼25% when spacer was 2 bp which was just above values
obtained with DNA targets having spacer of 3 and 5 bp
or the non-specific DNA target (Figure 5C). Similar data
were obtained when the truncated versions of mp53 and
hp53 lacking last 30 amino acid residues (mp5330 and
hp5330) were tested and reactions contained either Tris
or HEPES (Figure 5B and Supplementary Figure S4). In-
terestingly both murine and human30 derivatives showed
greater tendency to the p5330 tetramer multimerization
even without the presence of a DNA target as witnessed
by silver staining of proteins (Figure 5B). However, anal-
ysis of data obtained by IR scans showed that these C-
terminal truncates behaved similarly to the full-length p53,
and only gadd45 0 and gadd45 1 DNA targets were effi-
ciently bound by those multimeric complexes (Figure 5B
and C). The efficiency of the double tetramer formation for
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Figure 5. p53 multiple tetramers binding to DNA is most efficient when there is no spacer between half-sites. DNA targets containing different spacer
length between two gadd45 RE half-sites were used to test their ability to promote high molecular order p53-DNA complexes. (A) Both human and murine
p53 form multiple complexes on DNA targets with none (0 b) or one (1 bp) spacer between half-site sequences (gadd45 0 and gadd45 1, respectively) as
visualized from gel shifts where p53 was bound to IR dye-labeled DNA targets followed by silver-staining to visualize proteins. (B) Similar results were
obtained with murine mp30 truncated protein lacking the last 30 amino acids of the C-terminal domain. (C) IR signal ratio between various p53 tetramer
complexes (one, two and three tetramers) with different DNA targets was quantified to support the visual data in (A) and (B).
p5330 proteins was 10% and 20% higher for human and
murine p5330 proteins compared to the respective full-
length p53 proteins.
To further examine a role of the tetrameric organiza-
tion of p53 in multiple p53 tetramer/DNA complex for-
mation we used murine p53 mutant with the double sub-
stitution M340Q/L344R. This mutant p53 protein was re-
ported to form only dimers (55,56). Indeed, the dimeric p53
M340Q/L344R formed only a small amount of tetrameric
complexes in solution with a dimeric assembly being a
predominant form (Supplementary Figure S5). The fact
that mutated p53 has failed to facilitate oligomerization
on both specific and non-specific DNA targets implies that
tetrameric p53 architecture is required for multiple binding
to DNA RE (Supplementary Figure S5). This observation
was further corroborated by experiments with the cancer-
associated DNA-contact mutant of p53-R273H. Thus, the
DNA-binding deficient mutant formed tetramers as ex-
pected but failed to form complexes on both specific and
non-specific DNA targets (Supplementary Figure S6).
Electron microscopy analysis of p53-DNA complexes
The gel-shift analysis demonstrated that the DNA targets
with two immediately adjacent half-sites were the most ef-
ficient in promoting the multiple binding of p53 tetramers.
We thus used complexes formed on the gadd45 DNA target
(20 bp) to be visualized by electron microscopy using ro-
tary shadowing (Figure 6). Images of p53-DNA complexes
showedDNA-bound p53 particles that represented one p53
tetramer bound to DNA (Figure 6A, boxed in white) and
two p53 tetramers bound to one DNA RE (Figure 6A,
boxed in yellow). DNARE could be clearly seen in complex
with one p53 tetramer (Figure 6B) and two p53 tetramers
(Figure 6C).
We next showed that the cross-linked p53-DNA com-
plexes could also be well resolved on the native protein
PAGE (Supplementary Figure S7) prompting us to consider
extraction of specific complexes from the native gels and us-
ing them for electron microscopy image analysis via a mod-
ified gel-to-grid transfer method (57). The p53-DNA com-
plexes resolved by electrophoresis in native conditions were
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Figure 6. Electron microscopy of p53-DNA complexes. (A) Murine p53-
DNA (gadd45, 20 bp) complexes cross-linked with 0.025% GA (sam-
ple shown on Figure 3D, lane 8) were analyzed by Pt-Ir rotary shadow-
ing. White and yellow boxes highlight p53 tetramer–DNA and p53 dou-
ble tetramer–DNA complexes, respectively. Selected images are shown on
right side. DNA (red line) is seen in complex with single p53 tetramers (top
right) (B) and two p53 tetramers (bottom right), where two tetramers are
seen to bind to one DNA molecule, on opposite sides (C).
visualized by using the IR dye-labeled specific DNA target
(gadd45, 20 bp), then the gel zones containing complexes of
interest such as single, double and triple p53 tetramer–DNA
complexes were excised from the gel and blotted onto EM
grids (Supplementary Figure S8 and Materials and Meth-
ods). The images of single, double and triple p53 tetramer–
DNA complexes were selected from themicrographs of neg-
atively stained samples (Supplementary Figure S8B).
The majority of particles from the gel-section corre-
sponding to one tetramer of p53 bound to DNA were in-
deed single p53 tetramers, some of which had visible DNA
bound to them (Figure 7A, top row). Similarly, the majority
of particles from the double tetramer–DNAcomplexes were
represented by two p53 tetramers with DNA sandwiched in
between of them (Figure 7A, second row). Triple tetramer–
DNA complexes though enriched were less frequent in the
corresponding gel sections and the grid had a mixture of
double and triple tetramers bound to DNA due to insuffi-
cient distance between p53-DNA complexes on the native
gel in this area (Figure 7A, third row).
The representative class averages of p53 double tetramer–
DNA complexes obtained by the single particle analysis of
∼500 selected particles show two p53 tetramers bound to
oneDNARE (Figure 7B). Themodels corresponding to the
respective classes were obtained by combining two EM 3D
maps of p53 tetramers in complex with DNA (EMD-1896
(32)) and the crystal structure of two core domains bound
to the RE half-site (1ata (40)). The fitted core domains are
shown in red and yellow, and the general path of DNA is
shown in green (Figure 7C).
DISCUSSION
Tumor suppressor p53 is a transcriptional activator that
regulates expression of genes, products of which decide the
outcome of the cellular response to stress. The gene tran-
scription activation is achieved by p53 binding to its spe-
cific DNARE sequences (37,58,59). Much has been studied
about this process, however the elucidation of the precise
mechanism of how p53 tetramers bind RE DNA was hin-
dered by the lack of structural information about the full-
length p53 complexed with DNA.
To elucidate the mode by which p53 tetramers bindDNA
RE we cross-linked p53-DNA complexes with GA and re-
solved them on denaturing and native protein gels. Com-
plexes analyzed by native gels were visualized by the IR-
labeled DNA and transferred directly onto EM grids for
further image analysis. We believe that this combination of
methods, used to visualize specific p53-DNA complexes has
a broad potential for use in future studies of DNA binding
proteins in complex with various DNA targets. Using this
approachwe demonstrated that for both human andmurine
p53 one DNA RE element promotes binding of two p53
tetramers in a sequence-specific manner. The double p53
tetramer binding was only efficient when the p53-specific
DNA target consisted of two or more decameric half-sites
with 0 or 1 bp spacer in between them. No binding of mul-
tiple p53 tetramers was observed for either dimeric p53 or
DNA-binding deficient p53 proteins.
Similar DNA-binding by multiples of p53 tetramers, spe-
cific to the full length p53, has been reported in earlier stud-
ies that used chemical cross-linking by GA and EM visual-
ization (9,10,12,13). The observations were then interpreted
as a stack of p53 tetramers perpendicular to DNA, within
which only one p53 tetramer was bound toDNA, themodel
based on the crystallographic data of the isolated p53 core-
DNA complex (Figure 8A) (12,13). However, no explana-
tion was provided as to why the p53 tetramers could be
bound together in a stack-like manner.
Our combined biochemical and EM image analysis
of p53 tetramers bound to DNA RE showed that the
mode of interaction is different to that previously sug-
gested (22,40,43). Our results demonstrate that two p53
tetramers can interact sequence-specifically with one DNA
RE. The biochemical and electron microscopy image anal-
ysis showed that the DNA target is positioned between two
p53 tetramers, which occupy one half-site of RE each (Fig-
ure 7 and Supplementary Video). Thus, unlike the previ-
ously suggested mode of interaction the p53 tetramers are
positioned on the opposite side of the DNA molecule and
each tetramer is bound to one RE half-site essentially mak-
ing the decameric half-site, a prime binding sequence for
p53 tetramer (Figure 8B). This newly observed mode of in-
teraction is consistent with our previous EM structural data
that one p53 tetramer forms specific complex with DNA by
occupying only one half-site of the DNA RE (32).
Our new data is also in agreement with previous reports
that p53 can regulate transcription from non-canonical
DNA REs (60,61). p53 REs comprised from 3/4 of the
consensus RE (one half-site and one quarter site) and only
those from one half-site were shown to be functional in vivo
(37,60,61). The non-canonical p53 REs are less efficient and
appear to require higher levels of p53 for transactivation of
downstream genes. Their efficiency was shown to be on a
par with p53 REs where two canonical half-sites are sep-
arated by spacers longer than 5 bp (61). Importantly, the
most functionally efficient canonical p53 REs with two ad-
jacent half-sites (spacer <2 bp) such as REs from p21 and
gadd45 genes are also most efficient in double p53 tetramer
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Figure 7. Image analysis of p53-DNA complexes. (A) Images of p53-DNA complexes obtained by the gel-to-grid method and EM analysis. Top row –
complexes containing one p53 tetramer bound to DNA. The second row shows particles of p53 double tetramer–DNA complexes. The third row shows
particles of p53 triple tetramer–DNA complexes. p53 tetramers are highlighted with yellow circles andDNAwith red lines. (B) Representative class averages
of p53 double tetramer–DNA complexes show two p53 tetramers bound to one DNA RE (gadd45). DNA is indicated in red in the far right image. (C)
Models of two p53 tetramers bound to one DNA RE representing respective views in (B). Two cores pairs bound to half-site sequences (1ata, (36)) are
shown in red and yellow, and DNA is shown in green.
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Figure 8. Biological implications of the multiple p53 tetramers DNA RE binding. Schematic representation of possible biological implications for double
p53 tetramer binding to RE. (A) Old model of p53 tetramer interaction with DNA RE with a possible interaction between two p53 tetramers via protein
interactions that is not mediated by DNA RE. (B) New model of p53 tetramer interaction with DNA RE based on our data. One tetramer bound to a
half-site of the RE leaves the other half-site unoccupied providing an opportunity for a second p53 tetramer bind the remaining half-site and form the
two p53 tetramers complex with one DNA RE. Either complex serves as a platform for DNA looping by utilizing free core domains and facilitating more
efficient transcription activation. The ability to bind either side of the RE increases the probability of p53 finding it within the genomic context. (C) The
consequent binding of p53 tetramers to DNARE containing two or more half-sites can serve as a dose-dependent response in response to genotoxic stress
and rising levels of p53, providing another level of p53-dependent transcriptional regulation.
binding as we have shown in this work. Moreover, the p53
RE from TIGAR gene was more efficient in stimulating
multiple p53 tetramer DNA-binding when its natural 2 bp
spacer between two half-sites was removed (Supplementary
Figure S3).
This suggests a direct link between the structure of the
p53 RE, its ability to promote double p53 tetramer DNA-
binding and its transcriptional regulatory efficiency in vivo.
It also indicates that the RE half-site is the prime working
block for the tetrameric p53 RE DNA interaction and the
number and sequence conservation of half-sites define effi-
ciency and functionality of REs.
The results obtained raise the question why p53 RE has
evolved to have two or more decameric half-sites. It is
known that at least one half-site of RE is needed for an ini-
tial contact with p53 tetramer which makes it easier for p53
to locate its RE sites within the chromatin context. Once
the first p53 tetramer is bound to RE it may help to recruit
the second p53 tetramer to form two p53 tetramers per RE
complex. It can also recruit the chromatin remodeling ma-
chinery, which p53 is known to interact with. When the RE
is fully accessible it increases the probability p53 will bind
either part of the RE in genome. Having two p53 tetramers
bound to the RE would also provide a higher probability of
DNA looping since either tetramer can now be involved in
linking together distal REs (Figure 8B). In addition, having
two p53 tetramers bound to one DNA RE would increase
the chances of recruiting transcription co-factors needed for
gene expression. We believe that the multiple p53 tetramer
DNA-binding we describe here provides the answer to the
question and highlights the biological implications of this
p53 DNA-binding mode (Figure 8).
Interestingly the efficiency of multiple p53 tetramers
binding toDNAappears to be at its best when two half-sites
are immediately adjacent to each other. The ability of multi-
ple p53 tetramers to bind toDNAwas less efficient when the
spacer separating half-sites was longer than 1 bp, but was
more efficient again when the spacer was 15 bp-long. More-
over, inserting spacer longer than 1 bp into the gadd45-
derivedDNA target led to decrease of its ability to stimulate
multiple p53 tetramers complex formation for both murine
and human p53 proteins (Figure 5 and Supplementary Fig-
ure S4). This is consistent with a recent report on exper-
iments in vivo that p53 REs are most efficient when their
canonical half-sites are separated by less than 2 bp and show
a dramatic drop in efficiency when their half-sites are sepa-
rated by 5 bp or more (61). In this light it would be tempt-
ing to predict that some tetramer to tetramer contacts could
stabilize the overall complex of two p53 tetramers on the
two adjacent RE half-sites and that some post-translational
modifications of p53 may fine-tune such interactions.
The basic C-terminal domain of p53 has been implicated
in providing for p53’s complexes with non-specific DNA
and stabilizing p53 complexes with it specific REs (23–30).
Here, we tested human and murine p53 constructs lacking
the last C-terminal 30 amino acids (p5330) known to be
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responsible for those functions. Interestingly, the removal of
the basic C-terminal domain did not affect p53’s ability to
form multi-tetrameric complexes on DNARE targets (Fig-
ure 5 and Supplementary Figures S2 and S4) indicating that
the C-terminal regulatory domain of p53 does not provide
for the p53 multiple tetramer DNA-binding.
In addition, the p53R273H cancer-derived mutant that
does not to bind p53 DNA RE specifically but retains
the non-specific DNA-binding failed to form multi p53
tetramer complexes with DNA. Thus, confirming that the
non-specific DNA-binding of p53 does not contribute to
the multiple binding of p53 tetramers to DNA REs (Sup-
plementary Figure S6).
We have also demonstrated that the double p53 tetramer
DNA-binding to RE depends on the intact tetrameric or-
ganization of p53. Thus, the dimeric M340Q/L344R p53
mutant was not capable of forming complexes of multiple
p53 dimers on DNA targets despite its ability to bind p53
RE sequence specifically (55,56). Taken together with the
fact that both human and murine p53 protein are tetramers
in solution (Figure 1A and Supplementary Figure S1A) and
our previous structural data (31,32), these new results con-
firm that the tetrameric assembly of p53 takes place before
p53 binds its DNA RE and that tetramer is the functional
unit of p53. This is also consistent with previous biophysi-
cal data demonstrating that p53 tetramer is the fundamental
active unit of p53 (14,62).
The efficient binding of p53 tetramers to the DNA RE
also appears to depend on the RE primary sequence. Thus,
murine p53 tetramers formed double tetramer complexes
less efficiently than their human counterparts when canon-
ical human p21 and gadd45 REs were used, suggesting that
p53 tetramers acquire subtle conformational changes once
bound to DNA allowing them to stabilize the joint com-
plex. The data are in agreement with a report that efficiency
of p53 REs in transcriptional regulation is species-specific
(63).
One tetramer per half-site of RE DNA-binding mode
also supports the model of p53 level-dependent RE-binding
and p53 target genes promoter regulation suggested and dis-
cussed previously (61,63–65). The binding of p53 tetramers
to DNA RE containing two and more half-sites may serve
for a rheostat-like p53 dose-dependent activation of specific
genes in response to genotoxic stress and rising levels of p53,
providing another level of p53-dependent transcriptional
regulation (Figure 8C). Thus, promoters that have REs with
two half-sites would need less (only two) p53 tetramers to
fully activate them and promoters with REs that have more
than two decameric half-sites such as bax and mdm2 may
need higher levels of p53 and more than two p53 tetramers
to regulate their transactivation (63–65). This would be con-
sistent with data that rising levels of p53 tetramers in the cell
lead to higher rates of transactivation of the p53-regulated
genes (66,67).
In addition, one could hypothesise that the joint bind-
ing of p53 tetramers to REs may allow for some degree of
sequence degeneration due to potential cooperativity be-
tween p53 tetramers. Thus, degenerated half-sites within
non-canonical REs could be a good target for p53 when
the adjacent conserved half-sites have been already occu-
pied by p53 tetramers. In such a case, those p53 REs will be
fully functional at high levels of p53, e.g. the response from
those REs will be more p53 dose-dependent than from REs
that have two highly conservative half-site sequences with
no spacer between them. These results suggest that there is
an inherent adaptability in the recognition mechanism in
which the less canonical p53 REs compensate for their se-
quence degeneration and large spacer length between half-
sites by increasing numbers of half-sites in order to recruit
more p53 tetramers.
Finally, due to the ability of p63 and p73 to bind p53 REs
and transactivate p53 target genes and in agreement with
reports that p63 and p73 contribute to a p53 response (68–
73), some of the p53 family REs in our genome may serve
as platforms for joint binding of the p53/p63/p73 family
members to transcriptionally co-regulate downstreamgenes
they share.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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